Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1245499.RAbAL2zqU1RrqZnJKnm_iDDa5WkVTRLYCeltOoqJoB6D8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1245499.RAbAL2zqU1RrqZnJKnm_iDDa5WkVTRLYCeltOoqJoB6D8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1245499.RAbAL2zqU1RrqZnJKnm_iDDa5WkVTRLYCeltOoqJoB6D8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1245499.RAbAL2zqU1RrqZnJKnm_iDDa5WkVTRLYCeltOoqJoB6D8130_provenance.
- NP1245499.RAbAL2zqU1RrqZnJKnm_iDDa5WkVTRLYCeltOoqJoB6D8130_assertion description "[The poly(ADP-ribose) polymerase inhibitor olaparib has shown antitumour activity in patients with platinum-sensitive, recurrent, high-grade serous ovarian cancer with or without BRCA1 or BRCA2 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245499.RAbAL2zqU1RrqZnJKnm_iDDa5WkVTRLYCeltOoqJoB6D8130_provenance.
- NP1245499.RAbAL2zqU1RrqZnJKnm_iDDa5WkVTRLYCeltOoqJoB6D8130_assertion evidence source_evidence_literature NP1245499.RAbAL2zqU1RrqZnJKnm_iDDa5WkVTRLYCeltOoqJoB6D8130_provenance.
- NP1245499.RAbAL2zqU1RrqZnJKnm_iDDa5WkVTRLYCeltOoqJoB6D8130_assertion SIO_000772 25481791 NP1245499.RAbAL2zqU1RrqZnJKnm_iDDa5WkVTRLYCeltOoqJoB6D8130_provenance.
- NP1245499.RAbAL2zqU1RrqZnJKnm_iDDa5WkVTRLYCeltOoqJoB6D8130_assertion wasDerivedFrom befree-2016 NP1245499.RAbAL2zqU1RrqZnJKnm_iDDa5WkVTRLYCeltOoqJoB6D8130_provenance.
- NP1245499.RAbAL2zqU1RrqZnJKnm_iDDa5WkVTRLYCeltOoqJoB6D8130_assertion wasGeneratedBy ECO_0000203 NP1245499.RAbAL2zqU1RrqZnJKnm_iDDa5WkVTRLYCeltOoqJoB6D8130_provenance.
- befree-2016 importedOn "2016-02-19" NP1245499.RAbAL2zqU1RrqZnJKnm_iDDa5WkVTRLYCeltOoqJoB6D8130_provenance.